Phibro Animal Health | PAHC - 税前利润



金融业
股票价格
USD
资产
USD 1.45B
现金及等价物
USD 54.93M
销售成本
USD 240.42M
流动资产
USD 894.07M
流动负债
USD 281.87M
债务
USD 474.17M
股息收益率
1.29
EBIT
USD 54.99M
EBITDA
USD 68.1M
员工
1.92K
EPS每股收益
USD 0.78
股本和储备
USD 361.83M
销售毛利
USD 133.5M
债务利息支出
USD 11.91M
利息收入
USD 0.08
贷款资金
USD 597.69M
市值
USD 1.46B
净收入
USD 27.46M
营业费用
USD 361.83M
营业利润
USD 54.99M
普通股股本
USD 40.48M
PE价格收益
13.82
税前利润
USD 38.63M
销售收入
USD 373.91M
销售和管理费用
USD 78.32M
股票
USD 539.7M
贸易债权人
USD 129.64M
应收帐款人
USD 215.87M


税前利润 更改 日
Align Technology USD 148.69M 193K 2026-06
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Aurora Cannabis CAD 11.41M 12.99M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Canopy Growth CAD -157.96M 95.71M 2026-03
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
Henry Schein USD 150M 17M 2026-03
Idexx Laboratories USD 417.22M 61.78M 2026-06
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Merck USD -3.53B 6.95B 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Pacira USD 5M 4.43M 2026-03
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 64.77M 2.96M 2026-03
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06
Zoetis USD 758M 3M 2026-03